Cover Image
Market Research Report

Biosimulation Market - Size, Share, trends, and Forecast to 2026

Published by Coherent Market Insights Product code 678012
Published Content info 159 Pages
Delivery time: 2-3 business days
Price
Back to Top
Biosimulation Market - Size, Share, trends, and Forecast to 2026
Published: July 30, 2018 Content info: 159 Pages
Description

Biosimulation plays important role in research and development process. Biosimulation is widely used in consumer personalized medicine, owing to increasing demand for personalized medicine in offering tailored solutions for various treatment areas such as drug discovery, oncology, cardiology, infectious disease, and psychiatry. Predictive biosimulation offers effective platform to use biological data and mathematical modeling to create a virtual version of patient to test simulated treatments.

Moreover, continuous research is being conducted to create a low-priced or open source version of predictive biosimulation platforms for self-tracking and modeling using patient’s data and to speed up the adoption by software development communities to generate future health scenarios using patient’s medication data.

Market Dynamics

Market players are engaged in developing novel biosimulation platform, in order to offer tailored solution in each therapeutic area. This is expected to aid in growth of the market. For instance, in October 2013, Rhenovia Pharma: a biotechnology firm specialized in biosimulation has developed the first simulator for biological mechanism of epilepsy. Moreover, development of new simulator opens new possibilities for research in epilepsy treatment. Rhenovia’ new simulator replicates the basic biological mechanisms of signal transmission between brain cells and simulates its defects leading to epileptic patterns, thereby leading to prevent epileptic seizures.

Furthermore, growing support from heathcare regulatory organizations in the adoption of biosimulation based software and services will, augment future growth of biosimulation market. Current FDA and EMA guidelines recommends the use of biosimulation in pediatric drug development studies, thereby minimizing the impact on children that must enroll in clinical trials. For instance, in Novembr 2017, Certara stated that U.S. Food and Drug Administration (FDA), expanded its use of Certara’s PBPK Simcyp Population-based Simulator and its Pediatric and Cardiac Safety Simulators. In addition, under the new agreement, FDA has tripled its number of licenses, equipping its Modeling and Simulation (M&S) review team with almost 60 PBPK licenses.

Key features of the study:

This report provides in-depth analysis of biosimulation market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global biosimulation market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies and future plans

Key companies covered as a part of this study include Certara, L.P., Simulations Plus, Inc., Dassault Systèmes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrödinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera)

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global biosimulation market report caters to various stakeholders in this industry including investors, suppliers, biosimulation software and services provider, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the biosimulation market.

Detailed Segmentation:

  • Global Biosimulation Market, By Product & Services:
  • Software
  • Services
  • Global Biosimulation Market, By Application:
  • Drug Discovery
  • Drug Development
  • Global Biosimulation Market, By End User:
  • Pharmaceutical & Biotechnology Organizations
  • Contract Research Organizations(CROs)
  • Academic Research Institutions
  • Global Biosimulation Market, By Geography:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Product & Services:
  • Software
  • Services
  • By Application
  • Drug Discovery
  • Drug Development
  • By End User:
  • Pharmaceutical & Biotechnology Organizations
  • Contract Research Organizations (CROs)
  • Academic Research Institutions
  • Europe
  • By Country:
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Russia
  • Rest of Europe
  • By Product & Services:
  • Software
  • Services
  • By Application
  • Drug Discovery
  • Drug Development
  • By End User:
  • Pharmaceutical & Biotechnology Organizations
  • Contract Research Organizations (CROs)
  • Academic Research Institutions
  • Asia Pacific
  • By Country:
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • By Product & Services:
  • Software
  • Services
  • By Application
  • Drug Discovery
  • Drug Development
  • By End User:
  • Pharmaceutical & Biotechnology Organizations
  • Contract Research Organizations (CROs)
  • Academic Research Institutions
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Product & Services:
  • Software
  • Services
  • By Application
  • Drug Discovery
  • Drug Development
  • By End User:
  • Pharmaceutical & Biotechnology Organizations
  • Contract Research Organizations (CROs)
  • Academic Research Institutions
  • Latin America
  • By Country:
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • By Product & Services:
  • Software
  • Services
  • By Application
  • Drug Discovery
  • Drug Development
  • By End User:
  • Pharmaceutical & Biotechnology Organizations
  • Contract Research Organizations (CROs)
  • Academic Research Institutions
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Product & Services:
  • Software
  • Services
  • By Application
  • Drug Discovery
  • Drug Development
  • By End User:
  • Pharmaceutical & Biotechnology Organizations
  • Contract Research Organizations (CROs)
  • Academic Research Institutions
  • Company Profiles
  • Certara, L.P.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments
  • Strategies
  • Simulations Plus, Inc.
  • Dassault Systèmes (Accelrys)
  • Genedata AG
  • LeadScope, Inc.
  • Compugen Inc.
  • Schrödinger, LLC
  • In Silico Biosciences, Inc.
  • Advanced Chemistry Development, Inc.
  • Chemical Computing Group ULC
  • Physiomics PLC
  • Pharmaceutical Product Development, LLC (Evidera)
  • “*” marked represents similar segmentation in other categories in the respective section.
Table of Contents

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product & Services
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Market Trends
    • Merger and Acquisitions
    • New Product Approvals/Launch
    • PEST Analysis
    • Porter's Analysis

4. Global Biosimulation Market, By Product & Services, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Biosimulation Market, By Application, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Drug Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Biosimulation Market, By End User, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Pharmaceutical & Biotechnology Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Academic Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Biosimulation Market, By Regions, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2026
  • North America
    • Market Size and Forecast, By Product & Services, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, By Product & Services, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product & Services, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product & Services, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product & Services, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Northern Africa
  • Central Africa
  • South Africa
  • Middle East
    • Market Size and Forecast, By Product & Services, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • GCC Countries
  • Israel
  • Rest of Middle East

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Certara, L.P.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Simulations Plus, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Dassault Systemes (Accelrys)
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Genedata AG
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • LeadScope, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Compugen Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Schrodinger, LLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • In Silico Biosciences, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Advanced Chemistry Development, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Chemical Computing Group ULC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Physiomics PLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Pharmaceutical Product Development, LLC (Evidera)
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top